Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis

Gynecol Oncol. 2004 Apr;93(1):92-7. doi: 10.1016/j.ygyno.2003.12.042.

Abstract

Objectives: Determination of the frequency and tissue distribution of inhibin-alpha (INH-alpha) in normal, hyperplastic and malignant endometrium.

Materials and methods: Endometrial tissue was obtained from normal, hyperplastic (glandular-cystic hyperplasia), adenomatous hyperplasia (AH grade I to III) and endometroid adenocarcinoma and immunohistochemically characterized with INH-alpha antibody.

Results: INH-alpha was expressed in normal, hyperplastic and malignant endometrium. Highest expression was observed during secretory phase and glandular-cystic hyperplasia compared to all groups. A continuous decline was noted from AH grade I to III with a significance between AH I and II.

Discussion: A menstrual cycle associated expression of INH-alpha in glandular endometrial epithelium was observed. Since AH grade II and III can be considered as a precursor of endometrial cancer, INH-alpha could be a marker of cell transformation and an endometrial tumor-suppressor agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / biosynthesis*
  • Endometrial Neoplasms / metabolism*
  • Endometrial Neoplasms / pathology
  • Endometrium / metabolism*
  • Endometrium / pathology
  • Female
  • Humans
  • Hyperplasia
  • Immunohistochemistry
  • Inhibins / biosynthesis*
  • Precancerous Conditions / metabolism
  • Precancerous Conditions / pathology

Substances

  • Biomarkers, Tumor
  • inhibin-alpha subunit
  • Inhibins